Literature DB >> 12730773

Osteoporosis disease management in a rural health care population: hip fracture reduction and reduced costs in postmenopausal women after 5 years.

E D Newman1, W T Ayoub, R H Starkey, J M Diehl, G C Wood.   

Abstract

A 5 year observational study is reported which reviews the implementation of the Geisinger Health System Osteoporosis Disease Management Program. This program includes Osteoporosis Clinical Practice Guidelines, physician and allied health care provider education, community education, and a bone density testing program. All women over the age of 55 years enrolled in the Geisinger Health Plan (GHP) from 1996 to 2000 were included in this analysis. The guidelines led health care providers to increase the evaluation of osteoporosis via bone density measurements and to increase the prescription treatment of osteoporosis. Most importantly, the age-adjusted incidence of hip fractures fell significantly in the entire group as well as in several age strata (65-74, 75-84 and 85+ years). Compared with a predictive model of no intervention, there was an overall reduction in health care costs to GHP estimated to be US$7.8 million over a 5 year period. This report is the first to suggest that an organized Osteoporosis Disease Management Program delivered by a health care system can result in increased evaluation and treatment of osteoporosis with a resultant significant decrease in hip fractures while decreasing the total direct costs of care to a health plan.

Entities:  

Mesh:

Year:  2003        PMID: 12730773     DOI: 10.1007/s00198-002-1336-5

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  10 in total

1.  Prevention and treatment of osteoporosis. Clinical guidelines and new evidence.

Authors:  J Compston
Journal:  J R Coll Physicians Lond       Date:  2000 Nov-Dec

2.  Guidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone Disease.

Authors:  J A Kanis; P Delmas; P Burckhardt; C Cooper; D Torgerson
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

Review 3.  Diagnosis and management of osteoporosis in postmenopausal women: clinical guidelines. International Committee for Osteoporosis Clinical Guidelines.

Authors:  P J Meunier; P D Delmas; R Eastell; M R McClung; S Papapoulos; R Rizzoli; E Seeman; R D Wasnich
Journal:  Clin Ther       Date:  1999-06       Impact factor: 3.393

Review 4.  Postmenopausal osteoporosis treatment guidelines.

Authors:  P Sambrook; S O'Neill; T Diamond; L Flicker; A MacLennan
Journal:  Aust Fam Physician       Date:  2000-08

Review 5.  Evaluation and treatment of postmenopausal osteoporosis.

Authors:  L B Scheiber; L Torregrosa
Journal:  Semin Arthritis Rheum       Date:  1998-02       Impact factor: 5.532

Review 6.  Osteoporosis. Frequency, consequences, and risk factors.

Authors:  P D Ross
Journal:  Arch Intern Med       Date:  1996-07-08

7.  Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

Authors:  M R McClung; P Geusens; P D Miller; H Zippel; W G Bensen; C Roux; S Adami; I Fogelman; T Diamond; R Eastell; P J Meunier; J Y Reginster
Journal:  N Engl J Med       Date:  2001-02-01       Impact factor: 91.245

8.  Management of postmenopausal osteoporosis: position statement of the North American Menopause Society.

Authors: 
Journal:  Menopause       Date:  2002 Mar-Apr       Impact factor: 2.953

9.  Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.

Authors:  B Ettinger; D M Black; B H Mitlak; R K Knickerbocker; T Nickelsen; H K Genant; C Christiansen; P D Delmas; J R Zanchetta; J Stakkestad; C C Glüer; K Krueger; F J Cohen; S Eckert; K E Ensrud; L V Avioli; P Lips; S R Cummings
Journal:  JAMA       Date:  1999-08-18       Impact factor: 56.272

10.  Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation.

Authors:  N F Ray; J K Chan; M Thamer; L J Melton
Journal:  J Bone Miner Res       Date:  1997-01       Impact factor: 6.741

  10 in total
  32 in total

1.  High-risk osteoporosis clinic (HiROC): improving osteoporosis and postfracture care with an organized, programmatic approach.

Authors:  T P Olenginski; G Maloney-Saxon; C K Matzko; K Mackiewicz; H L Kirchner; A Bengier; E D Newman
Journal:  Osteoporos Int       Date:  2014-11-15       Impact factor: 4.507

2.  American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis: executive summary of recommendations.

Authors:  Nelson B Watts; John P Bilezikian; Pauline M Camacho; Susan L Greenspan; Steven T Harris; Stephen F Hodgson; Michael Kleerekoper; Marjorie M Luckey; Michael R McClung; Rachel Pessah Pollack; Steven M Petak
Journal:  Endocr Pract       Date:  2010 Nov-Dec       Impact factor: 3.443

3.  Bone density testing intervals and common sense.

Authors:  E Michael Lewiecki; Neil Binkley
Journal:  Curr Osteoporos Rep       Date:  2012-09       Impact factor: 5.096

4.  Impact of increased overweight on the projected prevalence of osteoporosis in older women.

Authors:  A C Looker; K M Flegal; L J Melton
Journal:  Osteoporos Int       Date:  2006-10-20       Impact factor: 4.507

Review 5.  Unmet needs in fracture prevention: new European guidelines for the investigation and registration of therapeutic agents.

Authors:  E Seeman
Journal:  Osteoporos Int       Date:  2007-02-17       Impact factor: 4.507

6.  Bone density testing: science, the media, and patient care.

Authors:  Micol S Rothman; Paul D Miller; E Michael Lewiecki; John P Bilezikian
Journal:  Curr Osteoporos Rep       Date:  2014-06       Impact factor: 5.096

7.  Multimorbidity in women with and without osteoporosis: results from a large US retrospective cohort study 2004-2009.

Authors:  C D O'Malley; N Tran; C Zapalowski; N Daizadeh; T P Olenginski; J A Cauley
Journal:  Osteoporos Int       Date:  2014-05-24       Impact factor: 4.507

8.  A team approach: implementing a model of care for preventing osteoporosis related fractures.

Authors:  M Giles; J Van Der Kallen; V Parker; K Cooper; K Gill; L Ross; S McNeill
Journal:  Osteoporos Int       Date:  2010-11-03       Impact factor: 4.507

9.  Bone: bone density screening leads to reduced fracture risk.

Authors:  Nelson B Watts
Journal:  Nat Rev Endocrinol       Date:  2010-01       Impact factor: 43.330

10.  American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis.

Authors:  Nelson B Watts; John P Bilezikian; Pauline M Camacho; Susan L Greenspan; Steven T Harris; Stephen F Hodgson; Michael Kleerekoper; Marjorie M Luckey; Michael R McClung; Rachel Pessah Pollack; Steven M Petak
Journal:  Endocr Pract       Date:  2010 Nov-Dec       Impact factor: 3.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.